VCEL Vericel Corp

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company. The Company operates in one reportable segment: the research, manufacture, and distribution of patient-specific, used in the treatment of specific diseases.

$27.17  -0.22 (-0.80%)
As of 05/23/2022 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/06/2001
Outstanding shares:  47,119,902
Average volume:  583,709
Market cap:   $1,309,462,077
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BSBMN89

---

Valuation   (See tab for details)

---

PE ratio:   -114.49
PB ratio:   7.53
PS ratio:   8.30
Return on equity:   -6.54%
Net income %:   -7.15%